Basic Science Catalyzing Treatments for Glaucoma
Basic Science Catalyzing Treatments for Glaucoma
批准号:
9391815
负责人:
W Daniel Stamer
金额:
$2.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2018-08-31
关键词:
AcademiaAreaAwardBackBasic ScienceBlindnessCellular biologyClinicalClinical ResearchCollaborationsDevelopmentDiagnosisDiseaseDisease ProgressionDoctor of MedicineDoctor of PhilosophyEnvironmentEthnic groupEyeFeedbackFellowshipFoundationsFunctional disorderFundingFutureGene MutationGlaucomaGoalsHomeostasisIndividualIndustryInstitutionInternationalKnowledgeLearningLocationMindMolecularMonitorMorehouse School of MedicineNatural regenerationOphthalmologistOptic DiskParticipantPathogenesisPathologyPatient CarePatientsPhysiologic Intraocular PressurePublic HealthRecording of previous eventsRecruitment ActivityResearchResearch PersonnelResourcesRetinal Ganglion CellsScientistSecureSenior ScientistSocietiesStructureStudentsTherapeuticTissuesTranslatingTranslational ResearchTranslationsTravelUnderrepresented MinorityUniversitiesVisionWomanWorkcareercareer developmentcell injuryeducational atmosphereethnic diversityimaging modalityinterestlecturesmeetingsneuroprotectionnew technologynovelpostersrole modelsocialstudent participationsymposiumtranslational impact
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
This proposal seeks support for the 2017 International Society for Eye Research (ISER)-BrightFocus
Foundation (BFF) glaucoma meeting titled "Basic Science Catalyzing Treatments for Glaucoma" to be held
October 5th – 7th, 2017 in Atlanta, Georgia at the Emory Conference Center Hotel. As with the inaugural
meeting that was held in Sarasota, FL in 2013, the goal of this meeting is to bring together basic scientists,
clinician-scientists, students and fellows for presentations and in-depth discussions on the molecular
mechanisms that underlie glaucomatous pathology, both at the level of the conventional outflow tract and
optic nerve head. Additionally, novel technologies developed (i) to diagnose and monitor disease
progression, (ii) modify/restore glaucomatous dysfunction and (ii) regenerate damaged cells/tissues will be
presented. We have already recruited 6 thought leaders in glaucoma to give keynote lectures at the
conference. As with the first meeting, the eleven platform sessions will be selected exclusively from
submitted abstracts. We have reserved one of the platform sessions and we are putting on a one-day "crash
course" in glaucoma exclusively for junior investigators, consistent with our goal of increasing student and
junior investigator participation. ISER and BFF have an established history for promoting diversity, and the
speakers that are selected from abstracts will represent a diverse group of scientists that includes women
and underrepresented individuals.
The Specific Aims of the conference are:
1. To enhance the emerging careers of 22 young scientists (including women and underrepresented
minorities) in glaucoma and increase student participation in the meeting by providing travel awards.
2. To provide a forum for dissemination of the most recent advances in the state of knowledge on
glaucoma.
3. To create an environment that will facilitate the exchange of novel ideas among basic and clinician
scientists and generate the opportunity for vision scientists of all ethnic groups and social
backgrounds to meet and establish research collaborations.
4. To bring together scientists working in disparate areas of glaucoma research.
We anticipate that this meeting will provide useful information on recent advances in glaucoma and will serve
as an important resource for those involved in the translation of these findings into suitable therapeutics.
This conference will also provide new opportunities, avenues for new discovery, and a forum to develop
potential collaborations among the attendees. The requested funds will support the travel, accommodation
and registration of 12 students (pre- and postdoctoral) and 10 junior investigators who otherwise would not
have the resources to attend this focused meeting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
"Concepts and Breakthroughs in Glaucoma" Conference
-
批准号:10317233
-
项目类别:
-
资助金额:$2.71万
-
财政年份:2021
-
负责人:W Daniel Stamer
-
依托单位:
Ocular Pharmacology and Therapeutics Conference
-
批准号:8837851
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2014
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN DYNAMICS AND GLAUCOMA
-
批准号:7015408
-
项目类别:
-
资助金额:$36.19万
-
财政年份:2006
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN DYNAMICS AND GLAUCOMA
-
批准号:7583931
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2006
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN DYNAMICS AND GLAUCOMA
-
批准号:7350116
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2006
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN DYNAMICS AND GLAUCOMA
-
批准号:7175368
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2006
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN DYNAMICS AND GLAUCOMA
-
批准号:7761661
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2006
-
负责人:W Daniel Stamer
-
依托单位:
SELENIUM-INDUCED GLAUCOMA
-
批准号:6830135
-
项目类别:
-
资助金额:$15.05万
-
财政年份:2003
-
负责人:W Daniel Stamer
-
依托单位:
SELENIUM-INDUCED GLAUCOMA
-
批准号:6986093
-
项目类别:
-
资助金额:$14.7万
-
财政年份:2003
-
负责人:W Daniel Stamer
-
依托单位:
SELENIUM-INDUCED GLAUCOMA
-
批准号:6703848
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2003
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN REGULATION OF AQUEOUS HUMOR OUTFLOW
-
批准号:6738013
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2002
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN REGULATION OF AQUEOUS HUMOR OUTFLOW
-
批准号:6470139
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2002
-
负责人:W Daniel Stamer
-
依托单位:
CADHERIN REGULATION OF AQUEOUS HUMOR OUTFLOW
-
批准号:6623768
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2002
-
负责人:W Daniel Stamer
-
依托单位:
Molecular Basis of Myocilin Function in the Human Eye
-
批准号:6371007
-
项目类别:
-
资助金额:$29.01万
-
财政年份:2001
-
负责人:W Daniel Stamer
-
依托单位:
Molecular Basis of Myocilin Function in the Human Eye
-
批准号:6904439
-
项目类别:
-
资助金额:$30.3万
-
财政年份:2001
-
负责人:W Daniel Stamer
-
依托单位:
Molecular Basis of Myocilin Function in the Human Eye
-
批准号:6518651
-
项目类别:
-
资助金额:$29.01万
-
财政年份:2001
-
负责人:W Daniel Stamer
-
依托单位:
Molecular Basis of Myocilin Function in the Human Eye
-
批准号:6769550
-
项目类别:
-
资助金额:$30.3万
-
财政年份:2001
-
负责人:W Daniel Stamer
-
依托单位:
MOLECULAR BASIS OF MYOCILIN FUNCTION IN THE HUMAN EYE
-
批准号:7373344
-
项目类别:
-
资助金额:$37.1万
-
财政年份:2001
-
负责人:W Daniel Stamer
-
依托单位:
Molecular Basis of Myocilin Function in the Human Eye
-
批准号:6603728
-
项目类别:
-
资助金额:$29.01万
-
财政年份:2001
-
负责人:W Daniel Stamer
-
依托单位:
Structural basis of ion channel function in Aquaporin-1
-
批准号:7151200
-
项目类别:
-
资助金额:$27.29万
-
财政年份:2000
-
负责人:W Daniel Stamer
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: